Protara Therapeutics, Inc. Operating Lease Right-of-Use Assets
Protara Therapeutics, Inc. (TARA) had Operating Lease Right-of-Use Assets of $2.60 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-11
- 2026-06-30: Operating Lease, Right-of-Use Asset $2.60M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $2.89M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $3.17M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $3.45M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $2.60M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $2.89M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $3.17M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $3.45M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $3.73M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $3.99M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $4.25M 10-K · filed 2026-03-10 |
| 2024-09-30 | $4.51M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $4.77M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $5.02M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $5.26M 10-K · filed 2025-03-05 |
| 2023-09-30 | $5.57M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $5.81M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $6.04M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $6.28M 10-K · filed 2024-03-13 |
| 2022-09-30 | $6.51M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $6.73M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $6.95M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $7.17M 10-K · filed 2023-03-08 |
| 2021-09-30 | $7.41M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $7.65M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.04M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $1.06M 10-K · filed 2022-03-09 |
| 2020-06-30 | $384.08K 10-Q · filed 2020-07-31 |
| 2020-03-31 | $391.52K 10-Q · filed 2020-05-13 |
| 2019-06-30 | $68.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $135.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |